In focus
Latest feed
Shattuck Labs Takes Flight: Goldman Sachs' Bold 'Buy' Rating Ignites Biotech Stock
Merck's Breakthrough: Islatravir-Doravirine Matches Leading HIV Treatment in Pivotal Trials
UK's Controversial Drug Price Hike: Pharma Giants Hit the Brakes on Investment
Senator Warren Sounds Alarm: Measles Surge Threatens, RFK Jr.'s CDC Panel Under Fire for Vaccine Delays